PPA notice
This article was originally published in The Tan Sheet
Executive Summary
FDA giving 13 NDA holders opportunity to object to withdrawal of approvals for PPA-containing products. An Aug. 14 Federal Register notice incorrectly stated 16 NDA products were involved (1"The Tan Sheet" Aug. 20, p. 14)
You may also be interested in...
PPA-Containing NDA Drugs, Weight-Control Aids Subject Of FDA Formal Notice
An FDA notice giving new drug application and ANDA holders an opportunity to object to FDA's plans to withdraw approval for PPA-containing decongestants also applies to manufacturers of extended-release weight-control products containing the ingredient, according to the agency.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands